Fucikova, J., Truxova, I., Hensler, M., Becht, E., Kasikova, L., Moserova, I., . . . Spisek, R. (2016). Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood.
Chicago ZitierstilFucikova, Jitka, et al. "Calreticulin Exposure By Malignant Blasts Correlates With Robust Anticancer Immunity and Improved Clinical Outcome in AML Patients." Blood 2016.
MLA ZitierstilFucikova, Jitka, et al. "Calreticulin Exposure By Malignant Blasts Correlates With Robust Anticancer Immunity and Improved Clinical Outcome in AML Patients." Blood 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.